It is a fixed-dose mixture product intended as continuation of therapy in sufferers with acute coronary syndrome already initiated with separate clopidogrel and aspirin products: Unstable angina or non-ST-elevation myocardial infarction in order to save you early and long-term atherothrombotic events (myocardial infarction, stroke, vascular dying or refractory ischaemia). CoPlavix is indicated for the treatment of acute coronary syndrome whether or now not patients go through cardiac revascularisation (surgical or PCI, with or without stent). ST-phase elevation acute myocardial infarction in order to save you atherothrombotic events. In this population, CoPlavix has been proven to reduce the fee of death from any cause and the price of a blended endpoint of death, re-infarction or stroke in medically dealt with sufferers eligible for thrombolytic remedy.
When not to use
Bleeding, Intracranial hemorrhage.
headaches or dizziness,Nausea,diarrhoea or constipation,indigestion (dyspepsia),stomach ache or abdominal pain,Nosebleeds,expanded bleeding (your blood taking longer to clot for example, when you narrow yourself), or easy bruising.